Logos Global Management

Latest statistics and disclosures from Logos Global Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Logos Global Management

Companies in the Logos Global Management portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alx Oncology Hldgs (ALXO) 23.3 $272M 3.2M 86.20
Olema Pharmaceuticals (OLMA) 15.4 $180M NEW 3.7M 48.08
Nkarta (NKTX) 8.9 $103M -17% 1.7M 61.47
Forma Therapeutics Hldgs SHS (FMTX) 4.2 $49M +19% 1.4M 34.90
Tg Therapeutics (TGTX) 3.8 $44M -51% 850k 52.02
Dyne Therapeutics (DYN) 2.9 $34M 1.6M 21.00
Athira Pharma (ATHA) 2.8 $33M -7% 948k 34.25
Keros Therapeutics (KROS) 2.7 $32M -71% 450k 70.54
Repare Therapeutics Ord (RPTX) 2.0 $23M -30% 677k 34.30
Kinnate Biopharma (KNTE) 1.9 $23M NEW 570k 39.78
Cogent Biosciences (COGT) 1.8 $22M NEW 1.9M 11.23
Bioxcel Therapeutics (BTAI) 1.7 $20M -21% 430k 46.20
Apellis Pharmaceuticals (APLS) 1.5 $17M NEW 300k 57.20
Biohaven Pharmaceutical Holding Call Option (BHVN) 1.5 $17M NEW 200k 85.71

Setup an alert

Logos Global Management will file the next quarterly 13-HR in about 1 months. Would you like to be notified?

Avidity Biosciences Ord (RNA) 1.5 $17M -6% 672k 25.52
Aligos Therapeutics (ALGS) 1.4 $17M NEW 607k 27.65
C4 Therapeutics Com Stk (CCCC) 1.4 $16M NEW 478k 33.13
Larimar Therapeutics (LRMR) 1.3 $15M +116% 715k 21.41
Compass Pathways Sponsored Ads (CMPS) 1.2 $14M -40% 300k 47.64
Silverback Therapeutics (SBTX) 1.2 $14M NEW 300k 46.34
Igm Biosciences (IGMS) 1.1 $13M NEW 150k 88.29
Karuna Therapeutics Ord (KRTX) 1.0 $12M NEW 120k 101.59
Abcellera Biologics (ABCL) 1.0 $12M NEW 300k 40.24
Mirati Therapeutics (MRTX) 0.9 $11M NEW 50k 219.64
Calliditas Therapeutics Ab Sponsered Ads (CALT) 0.9 $10M -45% 300k 33.62
Curis Com New (CRIS) 0.8 $9.8M NEW 1.2M 8.19
Kalvista Pharmaceuticals (KALV) 0.8 $9.3M +63% 490k 18.99
Miragen Therapeutics Com New 0.8 $9.0M NEW 550k 16.45
Passage Bio (PASG) 0.8 $8.8M 344k 25.57
Vincera Pharma Unit 12/24/2025 (VINCU) 0.7 $7.7M NEW 400k 19.26
Nurix Therapeutics (NRIX) 0.6 $7.6M -16% 230k 32.88
Therapeutics Acquisition Cor Com Cl A (RACA) 0.6 $7.0M 500k 13.92
Kymera Therapeutics (KYMR) 0.6 $6.9M -63% 111k 62.00
Essa Pharma Com New (EPIX) 0.6 $6.6M NEW 550k 11.93
Shattuck Labs (STTK) 0.5 $6.4M NEW 122k 52.41
Pmv Pharmaceuticals (PMVP) 0.5 $6.2M -33% 100k 61.51
Pulmonx Corp (LUNG) 0.4 $5.2M NEW 75k 69.03
Eyepoint Pharmaceuticals Com New (EYPT) 0.4 $4.6M NEW 700k 6.58
Annexon (ANNX) 0.3 $4.0M 160k 25.03
Black Diamond Therapeutics (BDTX) 0.3 $4.0M 124k 32.05
Health Sciences Acq Corp 2 Ord Shs (HSAQ) 0.3 $3.8M 300k 12.81
Vaxcyte (PCVX) 0.3 $3.7M NEW 140k 26.57
Harmony Biosciences Hldgs In (HRMY) 0.3 $3.6M -63% 100k 36.15
Bristol-myers Squibb Right 99/99/9999 0.3 $3.5M -8% 5.1M 0.69
Tokai Pharmaceuticals 0.3 $3.5M NEW 224k 15.40
Iteos Therapeutics (ITOS) 0.3 $3.4M -66% 100k 33.82
Outset Med (OM) 0.2 $2.8M -50% 50k 56.84
Panacea Acquisition Corp Unit 99/99/9999 0.2 $2.6M 200k 12.76
Bctg Acquisition Corp (BCTG) 0.2 $2.3M 200k 11.44
Helix Acquisition Corp Com Cl A (HLXA) 0.2 $2.3M NEW 200k 11.37
Eargo (EAR) 0.2 $2.2M NEW 50k 44.82
Opthea Sponsored Ads (OPT) 0.2 $1.8M NEW 160k 11.21
Pliant Therapeutics (PLRX) 0.1 $1.7M -44% 76k 22.71
Travere Therapeutics (TVTX) 0.1 $1.7M NEW 61k 27.26
Cerevel Therapeutics Hldng I (CERE) 0.1 $1.7M NEW 100k 16.58
Applied Molecular Trans (AMTI) 0.1 $1.3M NEW 43k 30.76
Fs Dev Corp Com Cl A 0.1 $1.1M 100k 11.00
Generation Bio (GBIO) 0.0 $482k NEW 17k 28.35
Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) 0.0 $188k NEW 33k 5.64

Past Filings by Logos Global Management

SEC 13F filings are viewable for Logos Global Management going back to 2019